Afinitor (chemical name: everolimus) is approved by the U.S. Food and Drug Administration to be used in combination with Aromasin (chemical name: exemestane) to treat advanced-stage, hormone-receptor-positive, HER2-negative breast cancer in postmenopausal women that has already been treated with Femara (chemical name: letrozole) or Arimidex (chemical name: anastrozole).
In this section you can learn more about:
- How Afinitor Works
- Will Afinitor Work for You?
- What to Expect When Taking Afinitor
- Afinitor Side Effects